GSK plc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
GSK plc. (GSK or 'the company'), formerly GlaxoSmithKline plc, is a developer, manufacturer, and marketer of vaccines, pharmaceuticals, over-the-counter (OTC) medicines and consumer healthcare products. The company offers medicines for various therapeutic areas, including respiratory, HIV, metabolic, anti-virals, urogenital, central nervous system, immuno-inflammation, cardiovascular, anti-bacterials and dermatology. GSK markets its products under Volibris, FluLaval, Bexsero, Menveo, Polident, Boostrix, Priorix, Otrivin, Theraflu, Aquafresh, and Imitrex brand names. It merchandises and sells these products through pharmacies, hospitals, wholesalers, and physicians worldwide. GSK has a business presence across the Americas, the Middle East, Africa, Australasia, and Europe. The company is headquartered in Brentford, Middlesex, the UK.Scope
- Detailed information on GSK plc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GSK plc. in the form of a SWOT analysis
- An in-depth view of the business model of GSK plc. including a breakdown and examination of key business segments
- Intelligence on GSK plc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GSK plc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of GSK plc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GSK plc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on GSK plc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- GSK plc.: Company Overview
- GSK plc.: Overview and Key Facts
- GSK plc.: Overview
- GSK plc.: Key Facts
- GSK plc.: Key Employees
- GSK plc.: Key Employee Biographies
- GSK plc.: Major Products and Services
- GSK plc.: Management Statement
- GSK plc.: Locations and Subsidiaries
- GSK plc.: Key Competitors
- GSK plc.: Company Analysis
- GSK plc.: Business Description
- GSK plc.: SWOT Analysis
- GSK plc.: SWOT Overview
- GSK plc.: Strengths
- GSK plc.: Weaknesses
- GSK plc.: Opportunities
- GSK plc.: Threats
- GSK plc.: Corporate Financial Deals Activity
- GSK plc.: Financial Deals Overview
- GSK plc.: Targets and Partners
- GSK plc.: Top Deals 2019 - 2023YTD*
- GSK plc.: Advisors
- GSK plc.: Top Legal Advisors
- GSK plc.: Top Financial Advisors
- GSK plc.: Mergers and Acquisitions
- GSK plc.: Corporate Venturing
- GSK plc.: Capital Raising
- GSK plc.: Partnership
- GSK plc.: Divestments
- GSK plc.: Recent Developments
- GSK plc.: News and Events Summary
- GSK plc.: Contracts
- GSK plc.: Financial Deals
- GSK plc.: Financial Performance
- GSK plc.: Grants
- GSK plc.: Market Developments
- GSK plc.: Research & Development
- GSK plc.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About the Publisher
- Table 1: GSK plc.: Key Facts
- Table 2: GSK plc.: Key Employees
- Table 3: GSK plc.: Locations and Subsidiaries
- Table 4: GSK plc.: Key Competitors
- Table 5: GSK plc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: GSK plc.: M&A Activity by Geography (TTM*)
- Table 7: GSK plc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
- Table 8: GSK plc.: M&A Average Deal Size - Value (US$m)
- Table 9: GSK plc.: Targets and Partners
- Table 10: GSK plc.: Top Deals 2019 - 2023YTD*
- Table 11: GSK plc.: Legal Advisor Ranking by Value (US$m)
- Table 12: GSK plc.: Financial Advisor Ranking by Value (US$m)
- Table 13: GSK plc.: M&A Volume and Value Trend (2019 - YTD*2023)
- Table 14: GSK plc.: M&A Activity by Geography (2019 - YTD*2023)
- Table 15: GSK plc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
- Table 16: GSK plc.: Corporate Venturing by Geography (2019 - YTD*2023)
- Table 17: GSK plc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
- Table 18: GSK plc.: Capital Raising by Deal Type (2019 - YTD*2023)
- Table 19: GSK plc.: Partnership Volume and Value Trend (2019 - YTD*2023)
- Table 20: GSK plc.: Partnership Trend by Deal Type (2019 - YTD*2023)
- Table 21: GSK plc.: Divestments Volume and Value Trend (2019 - YTD*2023)
- Table 22: GSK plc.: Divestments by Geography (2019 - YTD*2023)
- Table 23: GSK plc.: News and Events Summary
- Table 24: GSK plc.: Contracts
- Table 25: GSK plc.: Financial Deals
- Table 26: GSK plc.: Financial Performance
- Table 27: GSK plc.: Grants
- Table 28: GSK plc.: Market Developments
- Table 29: GSK plc.: Research & Development
- Table 30: GSK plc.: Strategy and Operations
- Figure 1: GSK plc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: GSK plc.: M&A Activity by Geography (TTM*)
- Figure 3: GSK plc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
- Figure 4: GSK plc.: M&A Average Deal Size - Value (US$m)
- Figure 5: GSK plc.: M&A Volume and Value Trend (2019 - YTD*2023)
- Figure 6: GSK plc.: M&A Activity by Geography (2019 - YTD*2023)
- Figure 7: GSK plc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
- Figure 8: GSK plc.: Corporate Venturing by Geography (2019 - YTD*2023)
- Figure 9: GSK plc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
- Figure 10: GSK plc.: Capital Raising by Deal Type (2019 - YTD*2023)
- Figure 11: GSK plc.: Partnership Volume and Value Trend (2019 - YTD*2023)
- Figure 12: GSK plc.: Partnership Trend by Deal Type (2019 - YTD*2023)
- Figure 13: GSK plc.: Divestments Volume and Value Trend (2019 - YTD*2023)
- Figure 14: GSK plc.: Divestments by Geography (2019 - YTD*2023)
